Teja Peddada

MD/PhD Student @StanfordMed, Kobilka Lab | B.S. @PittTweet ‘20

[Neuropsychopharmacology @npp_journal]

#TWiNPP

Finally, Akula et al. show that dysregulated allele-specific gene expression may help link genetic risk to structural brain abnormalities across multiple major psychiatric illnesses

https://t.co/kATexmlqVR

[Teja Peddada @TejaPeddada]

Grateful to have been a part of this work!

[Cell @CellCellPress]

Now online! Mechanism-guided identification of antidepressant G protein-coupled receptor drug targets https://t.co/Iupl54GUGa

[nature @Nature]

Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug tolerance or psychoactivity

https://t.co/R3Akj2sogH

[Vipin Rangari @Vipin36590264]

A Breakthrough in chronic pain treatment! 🚀 Our team designed VIP36, a peripherally restricted CB1 agonist that provides powerful pain relief without central side effects or tolerance. Targeting a cryptic pocket in CB1 receptor
https://t.co/Mq7vLpDg1z

[Teja Peddada @TejaPeddada]

Pleased to have contributed to this exome-wide association study investigating the genetic basis of treatment resistant depression!